Paraesophageal hernia repair with concurrent bariatric surgery: a single institution experience on safety, benefit, and outcomes in obese patients
摘要
Obesity is a significant risk factor for paraesophageal hernias (PEHs). While concurrent PEH repair and bariatric surgery have been shown to be safe when bariatric surgery is the primary indication, limited data exist on outcomes when PEH repair is the primary indication. This study evaluates the safety and benefits of concurrent bariatric surgery in obese patients undergoing PEH repair.
MethodsA retrospective cohort study was conducted using data from a single academic institution between 2010 and 2023. Patients who underwent PEH repair alone or with concurrent bariatric surgery – Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) – and had a body mass index (BMI) of 30 or more were included. Outcomes analyzed included hernia recurrence, 30-day complications, postoperative gastroesophageal reflux disease (GERD), dysphagia, and reoperation rates. Multivariable logistic regression models were used to assess risk factors for recurrence and complications.
ResultsA total of 526 patients with obesity met inclusion criteria: 296 (56.3%) underwent PEH repair alone, 128 (24.3%) underwent PEH repair with RYGB, and 102 (19.4%) underwent PEH repair with SG. Patients undergoing concurrent bariatric surgery had significantly lower hernia recurrence rates (PEH alone: 17.6% vs RYGB: 8.6% and SG: 7.8%; p < 0.01). Dysphagia was also less common in the bariatric cohorts (p < 0.01). However, RYGB patients had a higher 30-day complication rate (13.3%) compared to PEH alone (4.1%) and SG (2.0%) (p < 0.001). Obesity severity did not independently predict recurrence or complications.
ConclusionConcurrent bariatric surgery at the time of PEH repair is associated with reduced hernia recurrence and dysphagia without increasing overall major complications. These findings support a combined surgical approach in obese patients requiring PEH repair. Future prospective studies should further refine patient selection criteria.